Dozens of vulnerable House Democrats are worried that the party's stalled spending negotiations with Joe Manchin will cost them seats in the midterms — and hand Congress to the Republicans
Democrats planned to include legislation allowing Medicare to negotiate drug prices, fulfilling a campaign promise that helped them win control of the House in the "blue wave" of 2018, as part of President Joe Biden's Build Back Better legislation. The plan ran into an expensive lobbying blitz from the pharmaceutical industry, prompting Democrats to significantly water down the bill to limit the number of drugs Medicare could negotiate amid pushback from Sen. Kyrsten Sinema, D-Ariz., and other industry-aligned Democrats –– and that was before Manchin blew up the Build Back Better package entirely.
